NeoGenomics, Inc. Operating Lease, Liability, Noncurrent
NeoGenomics, Inc. (NEO) had Operating Lease, Liability, Noncurrent of $64.67 million as of 2026-06-30, per its 10-Q filed 2026-07-28.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:OperatingLeaseLiabilityNoncurrent · last filed 2026-07-28
- 2026-06-30: Operating Lease, Liability, Noncurrent $64.67M.
- 2026-03-31: Operating Lease, Liability, Noncurrent $61.46M.
- 2025-12-31: Operating Lease, Liability, Noncurrent $62.82M.
- 2025-09-30: Operating Lease, Liability, Noncurrent $64.33M.
| Period end | Operating Lease, Liability, Noncurrent |
|---|---|
| 2026-06-30 | $64.67M 10-Q · filed 2026-07-28 |
| 2026-03-31 | $61.46M 10-Q · filed 2026-04-28 |
| 2025-12-31 | $62.82M 10-Q · filed 2026-07-28 |
| 2025-09-30 | $64.33M 10-Q · filed 2025-10-28 |
| 2025-06-30 | $66.62M 10-Q · filed 2025-07-29 |
| 2025-03-31 | $59.86M 10-Q · filed 2025-04-29 |
| 2024-12-31 | $60.84M 10-K · filed 2026-02-17 |
| 2024-09-30 | $62.17M 10-Q · filed 2024-11-05 |
| 2024-06-30 | $63.29M 10-Q · filed 2024-07-30 |
| 2024-03-31 | $64.77M 10-Q · filed 2024-04-30 |
| 2023-12-31 | $67.87M 10-K · filed 2025-02-18 |
| 2023-09-30 | $62.01M 10-Q · filed 2023-11-06 |
| 2023-06-30 | $65.47M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $67.32M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $68.95M 10-K · filed 2024-02-20 |
| 2022-09-30 | $70.47M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $71.88M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $73.43M 10-Q · filed 2022-05-09 |
| 2021-12-31 | $72.29M 10-K · filed 2023-02-24 |
| 2021-09-30 | $72.34M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $49.62M 10-Q · filed 2021-08-09 |
| 2021-03-31 | $46.44M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $42.30M 10-K · filed 2022-02-25 |
| 2020-09-30 | $43.12M 10-Q · filed 2020-10-29 |
| 2020-06-30 | $44.52M 10-Q · filed 2020-07-31 |
| 2020-03-31 | $45.91M 10-Q · filed 2020-04-29 |
| 2019-12-31 | $24.03M 10-K · filed 2021-02-25 |
| 2019-09-30 | $23.87M 10-Q · filed 2019-11-13 |
| 2019-06-30 | $24.18M 10-Q · filed 2019-08-07 |
| 2019-03-31 | $16.65M 10-Q · filed 2019-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 20/20 Biolabs, Inc. (AIDX) | United States | $0.005B |